Worldwide, human vaccines exports by country totaled US$28 billion in 2018. That dollar amount represents a -4.1% decrease for all human vaccines shippers over the five-year period starting in 2014. Year over year, the value of exported human vaccines increased by 14.9% from 2017 to 2018.
Among continents, European countries sold the highest dollar worth of exported human vaccines during 2018 with shipments valued at $23.6 billion or 84.4% of the global total. In second place were North American exporters at 10.5% while 4.6% of worldwide human vaccines shipments originated from Asia. Smaller percentages came from Oceania (0.4%) led by Australia, Latin America (0.4%) then Africa (0.04%).
The 6-digit Harmonized Tariff System code prefix for human vaccines is 300220.
Top Human Vaccines Exports by Country
Below are the 15 countries that exported the highest dollar value worth of human vaccines during 2018.
- Belgium: US$6.4 billion (22.7% of total human vaccines exports)
- Ireland: $5.8 billion (20.9%)
- United Kingdom: $4.3 billion (15.3%)
- France: $3.8 billion (13.6%)
- United States: $2.4 billion (8.5%)
- Italy: $924.9 million (3.3%)
- India: $667.7 million (2.4%)
- Germany: $651.2 million (2.3%)
- Poland: $569.5 million (2%)
- Canada: $569.2 million (2%)
- Netherlands: $362.1 million (1.3%)
- Spain: $231.6 million (0.8%)
- Austria: $231.4 million (0.8%)
- South Korea: $165.9 million (0.6%)
- Singapore: $139.2 million (0.5%)
The listed 15 countries shipped 97% of all human vaccines exported in 2018 by value.
Among the top countries above, the fastest-growing human vaccines exporters since 2014 were: Poland (up 561.9%), Ireland (up 114.3%), United Kingdom (up 70%) and Austria (up 41.7%).
Those countries that posted declines in their exported human vaccines sales were led by: Netherlands (down -60.5%), Germany (down -39.7%), Belgium (down -39.6%), France (down -30.4%) and South Korea (down -14.5%).
The following countries posted the highest positive net exports for human vaccines during 2018. Investopedia defines net exports as the value of a country’s total exports minus the value of its total imports. Thus, the statistics below present the surplus between the value of each country’s exported human vaccines and its import purchases for that same commodity.
- Ireland: US$5.6 billion (net export surplus up 114.9% since 2014)
- France: $2.7 billion (up 75.9%)
- United Kingdom: $2.1 billion (up 93.4%)
- India: $351.7 million (up 4.7%)
- Italy: $306.7 million (up 53.7%)
- Netherlands: $212.2 million (reversing a -$607.6 million deficit)
- Austria: $163 million (up 75.9%)
- Singapore: $94.8 million (down -19.8%)
- Canada: $77.8 million (up 18%)
- Denmark: $19.8 million (down -75%)
- Bulgaria: $4.6 million (reversing a -$3.3 million deficit)
- North Korea: $1 million (down -69%)
- Senegal: $206,000 (reversing a -$2.1 million deficit)
- Cook Islands: $2,000 (reversing a -$3,000 deficit)
The Republic of Ireland has the highest surplus in the international trade of human vaccines. In turn, this positive cashflow confirms Ireland’s strong competitive advantage for this specific product category.
The following countries posted the highest negative net exports for human vaccines during 2018. Investopedia defines net exports as the value of a country’s total exports minus the value of its total imports. Thus, the statistics below present the deficit between the value of each country’s imported human vaccines purchases and its exports for that same commodity.
- United States: -US$3.4 billion (net export deficit up 200.8% since 2014)
- China: -$709 million (up 379.9%)
- Brazil: -$636.8 million (down -27.6%)
- Germany: -$535.1 million (down -20.7%)
- Japan: -$471.9 million (down -5%)
- Mexico: -$322.9 million (down -19.4%)
- Saudi Arabia: -$309.4 million (up 16.1%)
- Belgium: -$254.7 million (reversing a $3 billion deficit)
- Pakistan: -$247.6 million (down -14.2%)
- Poland: -$246.5 million (up 65.2%)
- Spain: -$210.4 million (up 65.3%)
- Australia: -$191.6 million (down -20.2%)
- Turkey: -$173 million (down -34.4%)
- Argentina: -$170 million (up 39%)
- Philippines: -$161.9 million (up 79.1%)
The United States of America incurred the highest deficit in the international trade of human vaccines. In turn, this negative cashflow highlights America’s competitive disadvantage for this specific product category but also signals opportunities for human vaccines-supplying countries that help satisfy the powerful consumer demand.
Human Vaccines Exporting Companies
Below are global human vaccines-processing conglomerates that represent the largest established players engaged in the international trade of human vaccines. Their city and home country for each corporation’s headquarters is shown within parenthesis.
- GlaxoSmithKline (London, UK)
- Merck & Co (Kenilworth, USA)
- Sanofi (Paris, France)
- Pfizer (New York, USA)
- Novavax (Rockville, USA)
- Emergent BioSolutions (Rockville, USA)
- CSL (Melbourne, Australia)
- Inovio Pharmaceuticals (Plymouth Meeting, USA)
- Bavarian Nordic (Kvistgaard, Denmark)
- Mitsubishi Tanabe (Tokyo, Japan)
The above list is ordered based on company size, according to 2018 rankings from the technavio Blog.
See also Heart Pacemaker Export Sales by Country, Drugs and Medicine Exports by Country and Top Blood Exporters by Country
Central Intelligence Agency, The World Factbook Field Listing: Exports – Commodities. Accessed on February 2, 2020
International Trade Centre, Trade Map. Accessed on February 2, 2020
Investopedia, Net Exports Definition. Accessed on February 2, 2020
Technavio Blog, Top 10 Vaccine Manufacturers in the World 2018. Accessed on February 2, 2020
Wikipedia, Vaccine. Accessed on February 2, 2020